ENERGEN
Report
- Report Number
- 2124215-2013-03520
- Event Type
- Injury
- Date Received
- April 10, 2013
- Date of Event
- February 22, 2013
- Report Date
- February 26, 2013
- Manufacturer
- GUIDANT CRM CLONMEL IRELAND
- Product Code
- LWS
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- OTHER
Narratives
WHEN ADDITIONAL INFORMATION BECOMES AVAILABLE, THIS EVENT WILL BE UPDATED.
AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
ADDITIONAL INFORMATION WAS OBTAINED. IT WAS DETERMINED THAT THE LEAD HAD BEEN PROGRAMMED TO TRIAD CONFIGURATION. ONCE PROGRAMMED, DFT TESTING REVEALED NORMAL SHOCK IMPEDANCE MEASUREMENTS. THIS DEVICE AND LEAD REMAIN IMPLANTED AND IN SERVICE.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT POST IMPLANT, THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (ICD) AND RIGHT VENTRICULAR LEAD DISPLAYED HIGH OUT OF RANGE SHOCK IMPEDANCE MEASUREMENTS. AN INTERNAL TECHNICAL SERVICE (TS) CONSULTANT WAS CONTACTED FOR THEIR RECOMMENDATIONS. REPORTEDLY, DEFIBRILLATION THRESHOLD (DFT) TESTING WAS PERFORMED, HOWEVER, THE RESULTS WERE NOT AVAILABLE AS OF THIS TIME. FURTHER SYSTEM INTEGRITY WAS RECOMMENDED. AS OF THIS TIME, THIS LEAD AND DEVICE REMAIN IMPLANTED AND IN SERVICE. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 153188 | ENERGEN | IMPLANTABLE CARDIOVERTER DEFIBRILLATOR | LWS | GUIDANT CRM CLONMEL IRELAND | F140 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| L| R |